Response to <scp>GPi</scp>‐<scp>DBS</scp> in a Case of <scp><i>EIF2AK2</i></scp>‐Associated Early‐Onset Generalized Dystonia

Ethical Compliance Statement: Informed patient consent was obtained. IRB approval was obtained through Boston Children's Hospital, Harvard Medical School (IRB-P00047069). We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflict of Interest: No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. Financial Disclosures of all Authors for the Previous 12 Months: S provides consultation for Best In Class MD. SR is employed by Emory University. KY has no financial disclosures. KY is employed by Boston Children's Hospital, Harvard Medical School. DE-F provides consultation for University of Texas Southwestern, German Center for Neurodegenerative Diseases, and Guidepoint LLC. DE-F is employed by Boston Children's Hospital, Harvard Medical School. DE-F has received speaker honoraria from The Movement Disorders Society and the Taiwan Society of Child Neurology. DE-F has obtained royalties from Cambridge University Press. DE-F has grants through National Institutes of Health, National Institute of Neurological Disorders and Stroke, CureAP4 Foundation, CureSPG50 Foundation, Spastic Paraplegia Foundation, Tom Wahlig Foundation, Un raggio di Sole per Martina, Manton Center for Orphan Disease Research, BCH Office of Faculty Development, and BCH Translational Research Program and Astellas Pharmaceuticals. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.